Antithrombotic monotherapy for stable coronary artery disease and atrial fibrillation patients with and without prior coronary artery revascularization: Insights from the AFIRE trial
                              
 
                                  Event:
                                  
                                    ESC Asia 2022 with APSC & AFC
                                  
 
                                  Topic:
                                  
                                    Treatment
                                  
 
                                  Session:
                                  
                                    Coronary Artery Disease / Acute Coronary Syndromes